CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis

Tissue Antigens

Volumn 53, Issue 1, 1999, Pages 106-110

  Flinstad Harbo, Hanne ^a   Gulowsen Celius, E ^b   Vartdal, F ^a   Spurkland, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

CTLA4; Exon 1; Multiple sclerosis; Polymorphisms; Promoter

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; CONTROLLED STUDY; EXON; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NORWAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0001394724     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530112.x     Document Type: Article

References (20)

1. 1. Ebers GC, Bulman DE, Sadovnick AD et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986: 315: 1638-42.
2. 2. Dyment DA, Sadovnick AD, Ebers GC, Sadnovich AD. Genetics of multiple sclerosis. Hum Mol Genet 1997: 6: 1693-8.
3. 3. Noel PJ, Boise LH, Green JM, Thompson CB. CD28 costimulation prevents cell death during primary T cell activation. J Immunol 1996: 157: 636-42.
4. 4. Dariavach P, Mattei MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988: 18: 1901-5.
5. 5. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991: 147: 1037-44.
6. 6. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res 1991: 19: 4018.
7. 7. Deichmann K, Heinzmann A, Bruggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem Biophys Res Commun 1996: 225: 817-8.
8. 8. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998: 51: 563-6.
9. 9. Donner H, Braun J, Seidl C et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 1997: 82: 4130-2.
10. 10. Donner H, Rau H, Walfish PG et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997: 82: 143-6.
11. 11. Donner H, Seidl C, Braun J et al. CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families. Diabetes 1998: 47: 1158-60.
12. 12. Marron MP, Raffel LJ, Garchon HJ et al. Insulin-dependent diabetes mellirus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997: 6: 1275-82.
13. 13. Seidl C, Donner H, Fischer B et al. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998: 51: 62-6.
14. 14. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995: 80: 41-5.
15. 15. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
16. 16. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996: 46: 907-11.
17. 17. Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer. Tissue Antigens 1997: 50: 15-22.
18. 18. Sambrook J, Fritsch EMT. Molecular cloning. A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989.
19. 19. Tiwari JL, Terasaki PI. The data and the statistical methods. In: Tiwari JL, Terasaki PI, eds. HLA and disease associations. New York: Springer Verlag, 1985: 18-27.
20. 20. Svejgaard A, Hauge M, Jersild C et al. The HLA system. An introductory survey. Monogr Hum Genet 1975: 7: 1-100.